AnnCatherine M. Downing

Genomewide association for schizophrenia in the CATIE study: results of stage 1

Patrick F. Sullivan, D. Y. Lin, J.‐W. Tzeng et al. · Molecular Psychiatry · 2008 · 361 citations · Full text

Genome-wide Association Study, Psychiatry, Genetics +9

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

Alette M. Wessels, Pierre N. Tariot, Jennifer A. Zimmer et al. · JAMA Neurology · 2019 · 191 citations · Full text

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

AnnCatherine M. Downing, Bruce J. Kinon, Brian A. Millen et al. · BMC Psychiatry · 2014 · 113 citations · Full text

A Haplotype of the Norepinephrine Transporter (Net) Gene Slc6a2 is Associated with Clinical Response to Atomoxetine in Attention-Deficit Hyperactivity Disorder (ADHD)

Nicolás Ramoz, Claudette Boni, AnnCatherine M. Downing et al. · Neuropsychopharmacology · 2009 · 56 citations · Full text

Adhd, Psychiatry, Attention-deficit Hyperactivity Disorder +11

Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer’s disease in an administrative claims database

Radhika Nair, Virginia S. Haynes, Mir S. Siadaty et al. · BMC Geriatrics · 2018 · 38 citations · Full text